Status: Not yet recruiting
Subthalamic Nucleus Versus Globus Pallidal Internus Deep Brain Stimulation for Parkinson Disease
The primary objective of this prospective, multicenter, double-blind, randomized, crossover clinical trial is to evaluate whether Subthalamic Nucleus-Deep Brain Stimulation (STN-DBS) is more effective than Globus Pallidus Internus-Deep Brain Stimulation (GPi-DBS) in improving motor symptoms of patients with Parkinson's disease at 90 days post-treatment.
Participants needed: 86
Trial details
Age: 22-75Biological sex: AllType: InterventionalSponsor: Zhang JianguoUpdated: Nov 26, 2025Locations: 8
Eligibility criteria
Age at the time of enrollment: 22-75 years. [+14]
Any intracranial abnormalities or medical conditions that Lead to the prohibitio... [+22]